Some 330 jobs hit as Novartis closes Morphosys, WiWo reports
BERLIN (Reuters) – Swiss pharmaceutical group Novartis is winding up the German biotech company Morphosys, which it acquired at the beginning of the year, German news outlet WirtschaftsWoche reported on Thursday, saying 330 jobs would be affected.
“In November 2024, we made the decision to close the Morphosys sites in Germany and the U.S. by the end of 2025 and to integrate all portfolio activities into Novartis,” WiWo cited Novartis as saying.
Novartis did not immediately respond to an emailed request for comment from Reuters.
($1 = 0.9610 euros)
(Writing by Friederike Heine; Editing by Madeline Chambers)
Related
Trump Must Take Proactive Approach to AI and Jobs
Artificial intelligence (AI) is rapidly disrupting America’s job market. Within the next decade, positions such as administrative assistants, cashiers, postal
Cotton, Crawford take top jobs on Senate, House intelligence committees…
Advertisement Advertisement Two Arkansans to lead Congress’ overs
Mark Cuban Says Trump’s Messaging Skills Overshadow Biden’s 16 Million…
When it comes to modern politics, it's not just about policies – it's about how you sell them. And according to billionaire entrepreneur Mark Cuban, Democrats
I’ve traveled and worked remotely for years. My parents thought…
I started working remotely in 2017 to combine international travel with my career.My parents thought that decision was reck
